Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Modulation of systemic antigen-specific immune responses by oral antigen in humans.

Kapp K, Maul J, Hostmann A, Mundt P, Preiss JC, Wenzel A, Thiel A, Zeitz M, Ullrich R, Duchmann R.

Eur J Immunol. 2010 Nov;40(11):3128-37. doi: 10.1002/eji.201040701. Epub 2010 Oct 19.

2.

Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity.

Liu L, Zhong Q, Tian T, Dubin K, Athale SK, Kupper TS.

Nat Med. 2010 Feb;16(2):224-7. doi: 10.1038/nm.2078. Epub 2010 Jan 17.

3.

Taking dendritic cells into medicine.

Steinman RM, Banchereau J.

Nature. 2007 Sep 27;449(7161):419-26. Review.

PMID:
17898760
4.

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.

Trumpfheller C, Finke JS, López CB, Moran TM, Moltedo B, Soares H, Huang Y, Schlesinger SJ, Park CG, Nussenzweig MC, Granelli-Piperno A, Steinman RM.

J Exp Med. 2006 Mar 20;203(3):607-17. Epub 2006 Feb 27.

5.

Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation.

Miller JS, Curtsinger J, Berthold M, Malvey K, Bliss RL, Le CT, Fautsch SK, Dudek AZ, Blazar BR, Panoskaltsis-Mortari A.

Clin Immunol. 2005 Nov;117(2):144-51. Epub 2005 Aug 19.

PMID:
16112616
6.

Intradermal influenza vaccination--can less be more?

La Montagne JR, Fauci AS.

N Engl J Med. 2004 Nov 25;351(22):2330-2. Epub 2004 Nov 3. No abstract available.

7.

Dose sparing with intradermal injection of influenza vaccine.

Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM.

N Engl J Med. 2004 Nov 25;351(22):2295-301. Epub 2004 Nov 3.

8.

Serum antibody responses after intradermal vaccination against influenza.

Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G.

N Engl J Med. 2004 Nov 25;351(22):2286-94. Epub 2004 Nov 3.

9.

Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men.

Smith TP, Kennedy SL, Fleshner M.

J Appl Physiol (1985). 2004 Aug;97(2):491-8.

10.

IMMUNOCHEMICAL STUDIES OF HEMOCYANIN FROM THE GIANT KEYHOLE LIMPET (MEGATHURA CRENULATA) AND THE HORSESHOE CRAB (LIMULUS POLYHEMUS).

MALLEY A, SAHA A, HALLIDAY WJ.

J Immunol. 1965 Jul;95:141-7. No abstract available.

PMID:
14322572
11.

Exploiting dendritic cells to improve vaccine efficacy.

Steinman RM, Pope M.

J Clin Invest. 2002 Jun;109(12):1519-26. Review. No abstract available.

12.

Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin.

Curtis JE, Hersh EM, Butler WT, Rossen RD.

J Lab Clin Med. 1971 Jul;78(1):61-9. No abstract available.

PMID:
5569250
13.

The human secondary immune response to Keyhole limpet haemocyanin.

Curtis JE, Hersh EM.

Clin Exp Immunol. 1972 Jan;10(1):171-7. No abstract available.

14.

Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Swanson MA, Schwartz RS.

N Engl J Med. 1967 Jul 27;277(4):163-70. No abstract available.

PMID:
4166031
15.

Editorial: Measurement of delayed skin-test responses.

Sokal JE.

N Engl J Med. 1975 Sep 4;293(10):501-2. No abstract available.

PMID:
1152865
16.

Investigations on allergic and serological reactions following inoculation of inactivated smallpox vaccines by cutaneous scarification.

Giurcă A, Topciu VL, Voiculescu D, Moldovan E, Plavoşin L.

Virologie. 1976 Jul-Sep;27(3):173-7.

PMID:
1006976

Supplemental Content

Support Center